|
TBL2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.79150052967725E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.39189999976064E-07 |
| Normal-vs-Stage2 |
1.167790E-02 |
| Normal-vs-Stage3 |
2.779700E-03 |
| Normal-vs-Stage4 |
1.295950E-02 |
| Stage1-vs-Stage2 |
5.551600E-01 |
| Stage1-vs-Stage3 |
2.548200E-01 |
| Stage1-vs-Stage4 |
3.235200E-01 |
| Stage2-vs-Stage3 |
2.130000E-01 |
| Stage2-vs-Stage4 |
1.545970E-01 |
| Stage3-vs-Stage4 |
8.749600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.56239515453672E-11 |
| Normal-vs-AfricanAmerican |
1.759810E-04 |
| Normal-vs-Asian |
1.616600E-01 |
| Caucasian-vs-AfricanAmerican |
3.810600E-01 |
| Caucasian-vs-Asian |
7.244600E-01 |
| AfricanAmerican-vs-Asian |
4.743000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.72039979221495E-10 |
| Normal-vs-Female |
1.47980000031467E-07 |
| Male-vs-Female |
9.685900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.264800E-03 |
| Normal-vs-Extreme_Weight |
1.50442999999889E-05 |
| Normal-vs-Obese |
1.02379999999958E-06 |
| Normal-vs-Extreme_Obese |
8.312400E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.042400E-01 |
| Normal_Weight-vs-Obese |
1.845360E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.073400E-01 |
| Extreme_Weight-vs-Obese |
3.174400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.170980E-01 |
| Obese-vs-Extreme_Obese |
5.206200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.155900E-04 |
| Normal-vs-Age(41-60Yrs) |
6.36399821729583E-11 |
| Normal-vs-Age(61-80Yrs) |
1.55592999999676E-05 |
| Normal-vs-Age(81-100Yrs) |
3.404600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.624100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.362500E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.029230E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.520000E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.482200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.828200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.66373598126302E-13 |
| Normal-VS-Type2 PRCC |
5.234300E-02 |
| Normal-VS-KIRP CIMP |
6.744900E-03 |
| Normal-VS-Unclassified PRCC |
9.228100E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.038900E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.565780E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.926200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.609300E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
1.044160E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.083500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.815240E-03 |
| Normal-vs-N1 |
2.319000E-03 |
| Normal-vs-N2 |
7.666100E-02 |
| N0-vs-N1 |
1.227050E-01 |
| N0-vs-N2 |
1.109230E-01 |
| N1-vs-N2 |
6.687600E-01 |
|
|
